Cart
sales@molnova.com
Varespladib methyl
CAS No. 172733-08-3
Varespladib methyl( A-002 | LY333013 )
Catalog No. M26858 CAS No. 172733-08-3
Varespladib methyl, a bioavailable prodrug of Varespladib, is a selective group II secretory phospholipase A2 inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 233 | In Stock |
|
| 2MG | 125 | In Stock |
|
| 5MG | 211 | In Stock |
|
| 10MG | 337 | In Stock |
|
| 25MG | 558 | In Stock |
|
| 50MG | 754 | In Stock |
|
| 100MG | 1032 | In Stock |
|
| 200MG | 1376 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameVarespladib methyl
-
NoteResearch use only, not for human use.
-
Brief DescriptionVarespladib methyl, a bioavailable prodrug of Varespladib, is a selective group II secretory phospholipase A2 inhibitor.
-
DescriptionVarespladib methyl, a bioavailable prodrug of Varespladib, is a selective group II secretory phospholipase A2 inhibitor. (In Vitro):Varespladib methyl display high-level secretory PLA2 inhibition at nanomolar and picomolar concentrations against 28 medically important snake venoms from six continents .
-
In Vitro——
-
In Vivo——
-
SynonymsA-002 | LY333013
-
PathwayOthers
-
TargetOther Targets
-
RecptorEndogenous Metabolite
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number172733-08-3
-
Formula Weight394.427
-
Molecular FormulaC22H22N2O5
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (253.54 mM)
-
SMILESCCc1c(C(=O)C(N)=O)c2c(OCC(=O)OC)cccc2n1Cc1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Morley SR, Forrest AR, Galloway JH. Validation of meconin as a marker for illicit opiate use. J Anal Toxicol. 2007 Mar;31(2):105-8.
molnova catalog
related products
-
Trachelogenin
Trachelogenin, an HCV entry inhibitor, has antiproliferative effects, and its mechanism is related to affecting the phosphorylation of key proteins in the β-Catenin signaling pathway, such as β-Catenin, c-Myc, and GSK3, in a concentration-dependent manner.
-
Orexin A (human, rat...
Endogenous agonist at orexin receptors (Ki values are 20 and 38 nM for OX1 and OX2 receptors respectively). Stimulates feeding following central administration and may be involved in the control of sleep-wake cycle and other hypothalamic functions.
-
7-O-Methylaloeresin ...
7-O-Methylaloeresin A shows significant antioxidant activity, it also has moderate inhibitory active on BACE.
